Download PDF
Semin Respir Crit Care Med 2003; 24(2): 213-222
DOI: 10.1055/s-2003-39020
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Genetics of Sarcoidosis

Manfred Schürmann
  • Institute of Human Genetics, University Lübeck, Lübeck, Germany.
Further Information

Publication History

Publication Date:
07 May 2003 (online)

    Permissions and Reprints

ABSTRACT

Sarcoidosis is a systemic disorder of granulomatous inflammation that primarily affects the lung and lymph system, although all organs can be involved. Two principal presentations of the disorder can be defined; an acute form, often with short duration and complete restitution, and a more insidious course with multiorgan involvement and a higher risk of progressive organ damage. Sarcoidosis affects mainly young adults.

The etiology of sarcoidosis is unknown, and current concepts assume one or more environmental triggers that start in a host with an inherited susceptibility to a dysbalanced immune response. Candidate susceptibility genes include genes with a function in antigen recognition, T cell activation, T-helper 1/2 (TH1/TH2) cell balance, and granuloma formation.

A few genetic linkage analyses and numerous association studies with a focus on the region of the major histocompatibility complex genes have been performed, which have so far yielded no breakthrough. They have, rather, verified the assumption of a complex and possibly heterogeneous character of the genetics of sarcoidosis.

KEYWORDS

Sarcoidosis - disease susceptibility - immunogenetics - major histocompatibility complex

REFERENCES

  • 1 Hunninghake G W, Costabel U, Ando M. et al . Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.  Am J Respir Crit Care Med . 1999;  160 736-755
    PubMedGoogle Scholar
  • 2 Newman L S, Rose C S, Maier L A. Sarcoidosis.  N Engl J Med . 1997;  336 1224-1234
    CrossrefPubMedGoogle Scholar
  • 3 Müller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application.  Eur Respir J . 1998;  12 716-738
    CrossrefPubMedGoogle Scholar
  • 4 Conron M, Du Bois M R. Immunological mechanisms in sarcoidosis.  Clin Exp Allergy . 2001;  31 543-554
    CrossrefPubMedGoogle Scholar
  • 5 Costabel U. Sarcoidosis: clinical update.  Eur Respir J . 2001;  18(suppl 32) S56-S68
    PubMedGoogle Scholar
  • 6 Milman N, Hoffmann A L, Byg K E. Sarcoidosis in children: epidemiology in Danes, clinical features, diagnosis, treatment and prognosis.  Acta Paediatr . 1998;  87 871-878
    CrossrefPubMedGoogle Scholar
  • 7 Nowak D A, Widenka D C. Neurosarcoidosis: a review of its intracranial manifestation.  J Neurol . 2001;  248 363-372
    CrossrefPubMedGoogle Scholar
  • 8 Bresnitz E A, Stolley P D, Israel H L, Soper K. Possible risk factors for sarcoidosis: a case-control study.  Ann N Y Acad Sci . 1986;  465 632-642
    PubMedGoogle Scholar
  • 9 Rybicki B A, Maliarik M J, Major M, Popovich Jr J, Iannuzzi M C. Epidemiology, demographics, and genetics of sarcoidosis.  Semin Respir Infect . 1998;  13 166-173
    PubMedGoogle Scholar
  • 10 Luisetti M, Beretta A, Casali L. Genetic aspects in sarcoidosis.  Eur Respir J . 2000;  16 768-780
    CrossrefPubMedGoogle Scholar
  • 11 McGrath D S, Goh N, Foley P J, du Bois M R. Sarcoidosis: genes and microbes: soil or seed?.  Sarcoidosis Vasc Diffuse Lung Dis . 2001;  18 149-164
    PubMedGoogle Scholar
  • 12 Cummings M M. An evaluation of the possible relationship of pine pollen to sarcoidosis (a critical summary).  Acta Med Scand Suppl . 1964;  425 48-50
    PubMedGoogle Scholar
  • 13 Terris M, Chaves A D. An epidemiologic study of sarcoidosis.  Am Rev Respir Dis . 1966;  94 50-55
    PubMedGoogle Scholar
  • 14 Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis: a 15-year European study.  Am Rev Respir Dis . 1984;  130 29-32
    PubMedGoogle Scholar
  • 15 Iwai K. Propionibacterium acnes in sarcoidosis.  Sarcoidosis . 1989;  6 73-75
    PubMedGoogle Scholar
  • 16 Kon O M, du Bois M R. Mycobacteria and sarcoidosis.  Thorax . 1997;  52(suppl 3) S47-S51
    PubMedGoogle Scholar
  • 17 Grosser M, Luther T, Muller J. et al . Detection of M. tuberculosis DNA in sarcoidosis: correlation with T-cell response.  Lab Invest . 1999;  79 775-784
    PubMedGoogle Scholar
  • 18 Eishi Y, Suga M, Ishige I. et al . Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis.  J Clin Microbiol . 2002;  40 198-204
    CrossrefPubMedGoogle Scholar
  • 19 Edmondstone W M, Wilson A G. Temporal clustering of familial sarcoidosis in nonconsanguineous relatives.  Br J Dis Chest . 1984;  78 184-186
    PubMedGoogle Scholar
  • 20 Fite E, Alsina J M, Mana J, Pujol R, Ruiz J, Morera J. Epidemiology of sarcoidosis in Catalonia: 1979-1989.  Sarcoidosis Vasc Diffuse Lung Dis . 1996;  13 153-158
    PubMedGoogle Scholar
  • 21 Wilsher M L. Seasonal clustering of sarcoidosis presenting with erythema nodosum.  Eur Respir J . 1998;  12 1197-1199
    CrossrefPubMedGoogle Scholar
  • 22 Padilla M L, Schilero G J, Teirstein A S. Donor-aquired sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis . 2002;  19 18-24
    PubMedGoogle Scholar
  • 23 Bellocq A, Lecossier D, Pierre-Audigier C, Tazi A, Valeyre D, Hance A J. T cell receptor repertoire of T lymphocytes recovered from the lung and blood of patients with sarcoidosis.  Am J Respir Crit Care Med . 1994;  149 646-654
    PubMedGoogle Scholar
  • 24 Klein J T, Horn T D, Forman J D, Silver R F, Teirstein A S, Moller D R. Selection of oligoclonal V beta-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis.  J Immunol . 1995;  154 1450-1460
    PubMedGoogle Scholar
  • 25 Grunewald J, Berlin M, Olerup O, Eklund A. Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis.  Am J Respir Crit Care Med . 2000;  161 814-818
    PubMedGoogle Scholar
  • 26 James D G. Epidemiology of sarcoidosis.  Sarcoidosis . 1992;  9 79-87
    PubMedGoogle Scholar
  • 27 Rybicki B A, Major M, Popovich Jr J, Maliarik M J, Iannuzzi M C. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.  Am J Epidemiol . 1997;  145 234-241
    CrossrefPubMedGoogle Scholar
  • 28 Edmondstone W M, Wilson A G. Sarcoidosis in Caucasians, blacks, and Asians in London.  Br J Dis Chest . 1985;  79 27-36
    CrossrefPubMedGoogle Scholar
  • 29 Pietinalho A, Hiraga Y, Hosoda Y, Lofroos A B, Yamaguchi M, Selroos O. The frequency of sarcoidosis in Finland and Hokkaido, Japan: a comparative epidemiological study.  Sarcoidosis . 1995;  12 61-67
    PubMedGoogle Scholar
  • 30 James D G, Neville E, Siltzbach L E. A worldwide review of sarcoidosis.  Ann N Y Acad Sci . 1976;  278 321-334
    CrossrefPubMedGoogle Scholar
  • 31 Baughman R P, Teirstein A S, Judson M A. et al . Clinical characteristics of patients in a case control study of sarcoidosis.  Am J Respir Crit Care Med . 2001;  164 1885-1889
    CrossrefPubMedGoogle Scholar
  • 32 Pietinalho A, Ohmichi M, Hiraga Y, Lofroos A B, Selroos O. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan: a comparative analysis of 571 Finnish and 686 Japanese patients.  Sarcoidosis Vasc Diffuse Lung Dis . 1996;  13 159-166
    PubMedGoogle Scholar
  • 33 Iwai K, Sekiguti M, Hosoda Y. et al . Racial difference in cardiac sarcoidosis incidence observed at autopsy.  Sarcoidosis . 1994;  11 26-31
    PubMedGoogle Scholar
  • 34 Wiman L G, Beskow R. Familial occurrence of sarcoidosis.  Scand J Respir Dis Suppl . 1972;  80 115-119
    PubMedGoogle Scholar
  • 35 Kirsten D. Sarcoidosis in Germany: analysis of a questionnaire survey in 1992 of patients of the German Sarcoidosis Group.  Pneumologie . 1995;  49 378-382
    PubMedGoogle Scholar
  • 36 Wirnsberger R M, de Vries J, Wouters E F, Drent M. Clinical presentation of sarcoidosis in the Netherlands: an epidemiological study.  Neth J Med . 1998;  53 53-60
    CrossrefPubMedGoogle Scholar
  • 37 McGrath D S, Daniil Z, Foley P. et al . Epidemiology of familial sarcoidosis in the UK.  Thorax . 2000;  55 751-754
    CrossrefPubMedGoogle Scholar
  • 38 Fite E, Alsina J M, Anto J M, Morera J. Sarcoidosis: family contact study.  Respiration . 1998;  65 34-39
    CrossrefPubMedGoogle Scholar
  • 39 Rybicki B A, Iannuzzi M C, Frederick M M. et al . Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS).  Am J Respir Crit Care Med . 2001;  164 2085-2091
    CrossrefPubMedGoogle Scholar
  • 40 MacGregor GA.. Sarcoidosis in husband and wife.  Lancet . 1978;  2 941-942
    PubMedGoogle Scholar
  • 41 Newman L S. Immunology, genetics, and epidemiology of beryllium disease.  Chest . 1996;  109(suppl 3) S40-S43
    PubMedGoogle Scholar
  • 42 Saltini C, Amicosante M. Beryllium disease.  Am J Med Sci . 2001;  321 89-98
    CrossrefPubMedGoogle Scholar
  • 43 Blau E B. Familial granulomatous arthritis, iritis, and rash.  J Pediatr . 1985;  107 689-693
    PubMedGoogle Scholar
  • 44 Manouvrier-Hanu S, Puech B, Piette F. et al . Blau syndrome of granulomatous arthritis, iritis, and skin rash: a new family and review of the literature.  Am J Med Genet . 1998;  76 217-221
    CrossrefPubMedGoogle Scholar
  • 45 Kreiss K, Mroz M M, Zhen B, Martyny J W, Newman L S. Epidemiology of beryllium sensitization and disease in nuclear workers.  Am Rev Respir Dis . 1993;  148 985-991
    CrossrefPubMedGoogle Scholar
  • 46 Newman L S. Beryllium disease and sarcoidosis: clinical and laboratory links.  Sarcoidosis . 1995;  12 7-19
    PubMedGoogle Scholar
  • 47 Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.  Science . 1993;  262 242-244
    CrossrefPubMedGoogle Scholar
  • 48 Saltini C, Richeldi L, Losi M. et al . Major histocompatibility locus genetic markers of beryllium sensitization and disease.  Eur Respir J . 2001;  18 677-684
    CrossrefPubMedGoogle Scholar
  • 49 Rossman M D, Stubbs J, Lee C W, Argyris E, Magira E, Monos D. Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity.  Am J Respir Crit Care Med . 2002;  165 788-794
    CrossrefPubMedGoogle Scholar
  • 50 Maier L A, Sawyer R T, Bauer R A. et al . High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease.  Am J Respir Crit Care Med . 2001;  164 1192-1199
    PubMedGoogle Scholar
  • 51 Amicosante M, Sanarico N, Berretta F. et al . Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69.  Hum Immunol . 2001;  62 686-693
    CrossrefPubMedGoogle Scholar
  • 52 James G. Blau's syndrome and sarcoidosis.  Lancet . 1999;  354 1035
    PubMedGoogle Scholar
  • 53 Tromp G, Kuivaniemi H, Raphael S. et al . Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16.  Am J Hum Genet . 1996;  59 1097-1107
    PubMedGoogle Scholar
  • 54 Podolsky D K. Inflammatory bowel disease.  N Engl J Med . 1991;  325 928-937
    PubMedGoogle Scholar
  • 55 Hugot J P, Laurent-Puig P, Gower-Rousseau C. et al . Mapping of a susceptibility locus for Crohn's disease on chromosome 16.  Nature . 1996;  379 821-823
    CrossrefPubMedGoogle Scholar
  • 56 Cavanaugh J A, Callen D F, Wilson S R. et al . Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16.  Ann Hum Genet . 1998;  62 291-298
    CrossrefPubMedGoogle Scholar
  • 57 Hugot J P, Chamaillard M, Zouali H. et al . Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.  Nature . 2001;  411 599-603
    CrossrefPubMedGoogle Scholar
  • 58 Ogura Y, Bonen D K, Inohara N. et al . A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.  Nature . 2001;  411 603-606
    CrossrefPubMedGoogle Scholar
  • 59 Hampe J, Cuthbert A, Croucher P J. et al . Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.  Lancet . 2001;  357 1925-1928
    CrossrefPubMedGoogle Scholar
  • 60 Miceli-Richard C, Lesage S, Rybojad M. et al . CARD15 mutations in Blau syndrome.  Nat Genet . 2001;  29 19-20
    CrossrefPubMedGoogle Scholar
  • 61 Iannuzzi M C. Genetics of sarcoidosis.  Monaldi Arch Chest Dis . 1998;  53 609-613
    PubMedGoogle Scholar
  • 62 Rybicki B A, Maliarik M J, Major M, Popovich Jr J, Iannuzzi M C. Genetics of sarcoidosis.  Clin Chest Med . 1997;  18 707-717
    CrossrefPubMedGoogle Scholar
  • 63 Verleden G M, du Bois M R, Bouros D. et al . Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin.  Eur Respir J . 2001;  32(suppl) S17-S29
    PubMedGoogle Scholar
  • 64 Schürmann M, Reichel P, Müller-Myhsok B, Schlaak M, Müller-Quernheim J, Schwinger E. Results from a genome-wide search for predisposing genes in sarcoidosis.  Am J Respir Crit Care Med . 2001;  164 840-846
    CrossrefPubMedGoogle Scholar
  • 65 Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.  Nat Genet . 1995;  11 241-247
    CrossrefPubMedGoogle Scholar
  • 66 Rybicki B A, Maliarik M J, Bock C H. et al . The Blau syndrome gene is not a major risk factor for sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis . 1999;  16 203-208
    PubMedGoogle Scholar
  • 67 Möller E, Hedfors E, Wiman L G. HL-A genotypes and MLR in familial sarcoidosis.  Tissue Antigens . 1974;  4 299-305
    PubMedGoogle Scholar
  • 68 Ina Y, Takada K, Yamamoto M, Morishita M, Senda Y, Torii Y. HLA and sarcoidosis in the Japanese.  Chest . 1989;  95 1257-1261
    PubMedGoogle Scholar
  • 69 Martinetti M, Tinelli C, Kolek V. et al . "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries.  Am J Respir Crit Care Med . 1995;  152 557-564
    PubMedGoogle Scholar
  • 70 Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis.  Am J Respir Crit Care Med . 1997;  156 1601-1605
    CrossrefPubMedGoogle Scholar
  • 71 Foley P J, McGrath D S, Puscinska E. et al . Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis.  Am J Respir Cell Mol Biol . 2001;  25 272-277
    CrossrefPubMedGoogle Scholar
  • 72 Planck A, Eklund A, Yamaguchi E, Grunewald J. Angiotensin-converting enzyme gene polymorphism in relation to HLA-DR in sarcoidosis.  J Intern Med . 2002;  251 217-222
    CrossrefPubMedGoogle Scholar
  • 73 Seitzer U, Gerdes J, Müller-Quernheim J. Evidence for disease phenotype associated haplotypes (DR.TNF) in sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis . 2001;  18 279-283
    PubMedGoogle Scholar
  • 74 Lympany P A, Petrek M, Southcott A M. et al . HLA-DPB polymorphisms: Glu 69 association with sarcoidosis.  Eur J Immunogenet . 1996;  23 353-359
    PubMedGoogle Scholar
  • 75 Foley P J, Lympany P A, Puscinska E, Zielinski J, Welsh K I, du Bois M R. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis.  Am J Respir Crit Care Med . 1999;  160 1009-1014
    PubMedGoogle Scholar
  • 76 Maliarik M J, Chen K M, Major M L. et al . Analysis of HLA-DPB1 polymorphisms in African Americans with sarcoidosis.  Am J Respir Crit Care Med . 1998;  158 111-114
    PubMedGoogle Scholar
  • 77 Schürmann M, Bein G, Kirsten D, Schlaak M, Müller-Quernheim J, Schwinger E. HLA-DQB1 and HLA-DPB1 genotypes in familial sarcoidosis.  Respir Med . 1998;  92 649-652
    CrossrefPubMedGoogle Scholar
  • 78 Schürmann M, Lympany P A, Reichel P. et al . Familial sarcoidosis is linked to the major histocompatibility complex region.  Am J Respir Crit Care Med . 2000;  162 861-184
    PubMedGoogle Scholar
  • 79 Tomlinson I P, Bodmer W F. The HLA system and the analysis of multifactorial genetic disease.  Trends Genet . 1995;  11 493-498
    CrossrefPubMedGoogle Scholar
  • 80 Moller D R. Cells and cytokines involved in the pathogenesis of sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis . 1999;  16 24-31
    PubMedGoogle Scholar
  • 81 Murakozy G, Gaede K I, Zissel G, Schlaak M, Müller-Quernheim J. Analysis of gene polymorphisms in interleukin-10 and transforming growth factor beta 1 in sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis . 2001;  18 165-169
    PubMedGoogle Scholar
  • 82 Niimi T, Sato S, Tomita H. et al . Lack of association with interleukin-1 receptor antagonist and interleukin-1beta gene polymorphisms in sarcoidosis patients.  Respir Med . 2000;  94 1038-1042
    PubMedGoogle Scholar
  • 83 Rybicki B A, Maliarik M J, Malvitz E. et al . The influence of T cell receptor and cytokine genes on sarcoidosis susceptibility in African Americans.  Hum Immunol . 1999;  60 867-874
    CrossrefPubMedGoogle Scholar
  • 84 Seitzer U, Swider C, Stuber F. et al . Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis.  Cytokine . 1997;  9 787-790
    CrossrefPubMedGoogle Scholar
  • 85 Labunski S, Posern G, Ludwig S, Kundt G, Brocker E B, Kunz M. Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum.  Acta Derm Venereol . 2001;  81 18-21
    PubMedGoogle Scholar
  • 86 Grutters J C, Sato H, Pantelidis P. et al . Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis.  Am J Respir Crit Care Med . 2002;  165 1119-1124
    CrossrefPubMedGoogle Scholar
  • 87 Takashige N, Naruse T K, Matsumori A. et al . Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis.  Tissue Antigens . 1999;  54 191-193
    CrossrefPubMedGoogle Scholar
  • 88 Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis.  Am J Med . 1975;  59 365-372
    CrossrefPubMedGoogle Scholar
  • 89 Gilbert S, Steinbrech D S, Landas S K, Hunninghake G W. Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease.  Am Rev Respir Dis . 1993;  148 483-486
    CrossrefPubMedGoogle Scholar
  • 90 Sharma P, Smith I, Maguire G, Stewart S, Shneerson J, Brown M J. Clinical value of ACE genotyping in diagnosis of sarcoidosis.  Lancet . 1997;  31(349) 1602-1603
    PubMedGoogle Scholar
  • 91 Furuya K, Yamaguchi E, Itoh A. et al . Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis.  Thorax . 1996;  51 777-780
    CrossrefPubMedGoogle Scholar
  • 92 Arbustini E, Grasso M, Leo G. et al . Polymorphism of angiotensin-converting enzyme gene in sarcoidosis.  Am J Respir Crit Care Med . 1996;  153 851-854
    PubMedGoogle Scholar
  • 93 Tomita H, Ina Y, Sugiura Y. et al . Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis.  Am J Respir Crit Care Med . 1997;  156 255-259
    PubMedGoogle Scholar
  • 94 McGrath D S, Foley P J, Petrek M. et al . Ace gene I/D polymorphism and sarcoidosis pulmonary disease severity.  Am J Respir Crit Care Med . 2001;  15(164) 197-201
    PubMedGoogle Scholar
  • 95 Pietinalho A, Furuya K, Yamaguchi E, Kawakami Y, Selroos O. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients.  Eur Respir J . 1999;  13 723-726
    CrossrefPubMedGoogle Scholar
  • 96 Papadopoulos K I, Melander O, Orho-Melander M, Groop L C, Carlsson M, Hallengren B. Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases.  J Intern Med . 2000;  247 71-27
    CrossrefPubMedGoogle Scholar
  • 97 Maliarik M J, Rybicki B A, Malvitz E. et al . Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis.  Am J Respir Crit Care Med . 1998;  158 1566-1570
    PubMedGoogle Scholar
  • 98 Schürmann M, Reichel P, Müller-Myhsok B. et al . Angiotensin-converting enzyme (ACE) gene polymorphisms and familial occurrence of sarcoidosis.  J Intern Med . 2001;  249 77-83
    CrossrefPubMedGoogle Scholar
  • 99 Rutherford R M, Kehren J, Staedtler F. et al . Functional genomics in sarcoidosis: reduced or increased apoptosis?.  Swiss Med Wkly . 2001;  131 459-470
    PubMedGoogle Scholar
  • 100 Thonhofer E, Maercker C, Popper H H. Expression of sarcoidosis-related genes in lung lavage cells.  Sarcoidosis Vasc Diffuse Lung Dis . 2002;  19 59-64
    PubMedGoogle Scholar